Mavacoxib is a selective cyclooxygenase-2 inhibitor belonging to the oxicam class of nonsteroidal anti-inflammatory drugs, widely utilized in veterinary medicine to manage pain and inflammation associated… Read more
Mavacoxib is a selective cyclooxygenase-2 inhibitor belonging to the oxicam class of nonsteroidal anti-inflammatory drugs, widely utilized in veterinary medicine to manage pain and inflammation associated with degenerative joint disease in dogs. By blocking COX-2 enzymes, this medication effectively reduces prostaglandin synthesis in affected animals. This category provides essential analytical reference standards for Mavacoxib, including its stable isotope labelled analogues like Mavacoxib-d4, as well as pharmacopeial and non-pharmacopeial impurities. These compounds serve as critical tools for pharmaceutical laboratories engaged in impurity profiling, method validation, and rigorous quality control testing. Utilizing high-quality reference materials ensures the accuracy of analytical procedures, helping researchers and quality assurance professionals maintain regulatory compliance and verify the purity and stability of drug formulations throughout the development and manufacturing process.